Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)

Antonio Saad, Lucy Chappell, George Saade, Luis D. Pacheco

Research output: Contribution to journalReview articlepeer-review

49 Scopus citations


Recent evidence supports the use of an early, short course of glucocorticoids in patients with COVID-19 who require mechanical ventilation or oxygen support. As the number of coronavirus disease 2019 (COVID-19) cases continues to increase, the number of pregnant women with the disease is very likely to increase as well. Because pregnant women are at increased risk for hospitalization, intensive care unit admission, and mechanical ventilation support, obstetricians will be facing the dilemma of initiating maternal corticosteroid therapy while weighing its potential adverse effects on the fetus (or neonate if the patient is postpartum and breastfeeding). Our objective is to summarize the current evidence supporting steroid therapy in the management of patients with acute respiratory distress syndrome and COVID-19 and to elaborate on key modifications for the pregnant patient.

Original languageEnglish (US)
Pages (from-to)823-826
Number of pages4
JournalObstetrics and gynecology
Issue number4
StatePublished - Oct 1 2020

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)'. Together they form a unique fingerprint.

Cite this